(Credit-Canva)
COVID vaccines have often been at the center of discussions, mostly for their side effects and potential risks. But this time the spotlight is on something positive - COVID vaccine is being linked to prolonging the life of cancer patients. But not every COVID vaccine, only mRNA.
Scientists at the University of Florida and the University of Texas MD Anderson Cancer Center discovered something very important. They found that people with serious lung or skin cancer who got an mRNA COVID-19 vaccine around the time they started their anti-cancer treatment, which is immunotherapy, lived much longer than those who didn't get the shot. Specifically, the vaccine seemed helpful if it was given within 100 days of starting the cancer treatment.
Also Read: Is Bubble Tea Putting Your Health at Risk? Experts Warn About Lead Exposure
This discovery is a huge leap forward in the research to use mRNA technology—the same tech used for the COVID shots—to teach the body's natural defense system to fight cancer. It builds on previous studies and brings us closer to a potential universal cancer vaccine that could make existing cancer drugs work even better for more people.
The new study, which was written about in the journal Nature, comes from eight years of work by Dr. Sayour on mixing tiny fat bubbles with mRNA. mRNA is a natural material in your body that carries the blueprint for making proteins.
Dr. Sayour's lab previously had an unexpected finding: to make the immune system strongly attack a tumor, they didn't have to target a specific piece of the cancer. Instead, they could just boost the immune system as if it were getting ready to fight a virus. This led to an experimental mRNA shot (similar to the COVID vaccines) that, when mixed with standard cancer drugs, strongly fought tumors in mice.
This success made another team member, Dr. Adam Grippin, wonder: Could the standard COVID-19 mRNA vaccine act the same way as their experimental "nonspecific" one? To find out, the researchers looked at the medical records of patients with advanced lung and skin cancers treated between 2019 and 2023.
The Mayo Clinic explains that the mRNA vaccine gives your cells a set of instructions on how to build the harmless spike protein that is on the COVID-19 virus. The vaccine sends the mRNA into your muscle and your muscle cells or other defense cells read these instructions and start making the spike protein. This is how your body prepares to protect you from the virus. Moderna and Pfizer-BioNTech are both mRNA vaccines available in the US.
Also Read: Not All Antidepressants Affect Your Body The Same; Here’s What You Need To Know About Side Effects
These findings come from checking the medical files of over 1,000 patients. It's important to know that this is only the first look at the information. Scientists must confirm these results in a strict new study called a randomized clinical trial. If the results hold up, this study could change cancer treatment forever.
The study clearly shows how powerful mRNA medicines are. The findings also point to an unexpected benefit from the government's quick push for COVID-19 vaccines (called Operation Warp Speed), showing how that effort continues to help save American lives.
The data analysis showed that getting a COVID mRNA vaccine within 100 days of starting cancer drugs was linked to significantly longer lives. This was most true for patients whose bodies weren't expected to fight their tumors very well on their own.
For 180 advanced lung cancer patients who got the vaccine, the average survival time was nearly doubled, going from 20.6 months to 37.3 months, compared to patients who didn't get the shot. For patients with widespread skin cancer (melanoma), the average survival went up from 26.7 months to somewhere between 30 and 40 months. Importantly, getting non-mRNA shots, like the regular flu vaccine, did not change survival time.
To make sure their findings were real, the UF researchers did experiments with mice, giving them immunotherapy drugs along with an mRNA vaccine for the COVID virus. These tests showed that the combination could make cancers that usually ignored treatment suddenly shrink and stop growing.
The next necessary step is to launch a big clinical trial to confirm these findings. If they are proven true, scientists could design an even better, general-purpose vaccine to help cancer patients. For people with late-stage cancer, the extra time they gain from this kind of treatment would be priceless. Dr. Sayour believes that even a small boost in survival, like 5% or 10%, means a huge amount to these patients, especially if this treatment can work for many different kinds of cancer.
Credit: iStock
The American Heart Association (AHA), in its latest update on nutrition guidance, has urged the need to eat a diet rich in vegetables and fruits, while also making a key shift to plant-based protein from meat-based protein earlier to improve heart health.
It has also emphasized the need to reduce the intake of sugar, salt and ultra-processed foods, as well as to switch to low-fat dairy.
The scientific statement, which is issued about every five years, comes amid increasing cases of high blood pressure and obesity in the US, which can potentially lead to poor health outcomes, including deaths from cardiovascular disease and other chronic conditions.
“For healthy eating to be more attainable and sustainable, we recommend people focus on their overall eating pattern rather than specific nutrients or foods. This approach is actionable, something that can be modified as people pass through different life stages, while still adhering to the nine key features,” said Alice H. Lichtenstein, volunteer chair of the scientific statement writing committee and senior scientist.
“The guidance applies to wherever you eat: at home, school, work, restaurants, or in your community. You want to strive for progress rather than perfection. Every time you choose to make a swap for a healthier alternative, you’re making a step toward a healthier life,” added Lichtenstein, who is also senior scientist at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Boston.
The 9 Guidelines for a heart-healthy dietary pattern include:

Also read: AHA’s New Dyslipidemia Guidelines Stress Early Screening, Lifestyle Management
The 2026 guidance for children recommends a heart‑healthy dietary pattern starting at 1 year of age. It urges families to play a significant role and become role models.
“Cardiovascular disease begins early in life; even prenatal factors can contribute to increased risk in children as they grow. So, it’s important that healthy eating patterns are adopted in childhood and continue throughout the entire lifespan,” Lichtenstein said.
“The best way to do that is for adults to role model heart-healthy eating patterns inside and outside the home,” she added.
Also read: Cardiovascular Diseases Lead As India’s Top Killer: US Cardiologist Points Out Risk Factors
While the updated guidance is specifically designed to improve cardiovascular health, it may also help improve other conditions like type 2 diabetes, kidney disease, some cancers, and brain health.
Credit: Freepik
Breast cancer treatment has evolved significantly over the past few decades, moving from radical removal approaches to more personalized and tissue-preserving techniques. Today, surgeons no longer view breast conservation surgery (BCS) and mastectomy as competing options, but as equally effective strategies chosen based on individual patient needs.
With the growing availability of reconstructive surgery in Kolkata, patients now also have better cosmetic and psychological outcomes regardless of the surgical path they choose.
When faced with a breast cancer diagnosis, understanding the available surgical options is crucial for making an informed decision. Each approach is designed to effectively treat the disease while considering the patient’s long-term health, comfort, and quality of life.
Breast conservation surgery, or lumpectomy or partial mastectomy, is a procedure that involves the removal of the tumor and a small amount of surrounding healthy tissue while preserving most of the breast.
The main objective is to remove cancer without altering the natural shape and appearance of the breast. Radiation therapy is usually administered after surgery to kill any remaining cancer cells and minimize the chances of recurrence.
Mastectomy is the removal of the whole breast tissue, and in other cases, the lymph nodes and skin around the breast. It can be done on either breast or both breasts based on the type of cancer and risk factors.
After a mastectomy, patients can choose to have breast reconstruction with the help of modern surgical procedures, such as those provided in reconstructive surgery in Kolkata, which can help to restore the shape and symmetry of the breast.
The basic distinction is the degree of tissue excision. BCS leaves the majority of the breast, but a mastectomy takes away all of it.
| Factor | Breast Conservation Surgery (BCS) | Mastectomy |
| Extent of Surgery | Removes tumor with a small margin of healthy tissue | Removes entire breast tissue |
| Invasiveness | Less invasive | More extensive surgery |
| Cosmetic Outcome | Preserves most of the natural breast shape | The breast is removed (reconstruction may be needed) |
| Recovery Time | Generally faster recovery | Longer recovery period |
| Radiation Therapy | Usually required after surgery | May or may not be required |
| Risk of Recurrence | Slightly higher local recurrence risk | Lower local recurrence risk |
| Hospital Stay | Often shorter or a day-care procedure | May require a longer hospital stay |
| Suitability | Early-stage cancer, smaller tumors | Larger tumors, multiple areas, or high-risk cases |
| Impact on Body Image | Better preservation of body image | May impact body image (can be improved with reconstruction) |
Notably, several studies indicate that both methods have equal chances of survival in the long term in early-stage breast cancer.
Not every patient is suited for the same surgical approach, as the choice largely depends on individual clinical factors. Tumor size, stage, location, and overall health all play a crucial role in determining eligibility. Understanding who can opt for which procedure helps ensure both effective treatment and optimal long-term outcomes.
Candidates for Breast Conservation Surgery
BCS is usually prescribed to patients with:
It might not apply to patients who have more than one tumor in other parts of the breast or those with advanced disease.
Candidates for Mastectomy
Mastectomy may be suggested when:
Moreover, other patients might opt to undergo mastectomy to have a sense of security or to alleviate the fear of recurrence.
The current surgical advances have greatly enhanced the results, particularly in patients who want to preserve their breasts.
Oncoplastic Surgery
Among the most remarkable developments is the oncoplastic breast surgery that involves the use of both cancer resection and plastic surgery. This enables the surgeons to excise bigger tumors without altering the shape and symmetry of the breast.
This has increased the eligibility of BCS so that more women can avoid mastectomy and still have safe control of cancer.
Improved Imaging and Targeting
Modern imaging techniques have assisted surgeons in accurately identifying tumors so that they can be fully removed without damaging normal tissue. This enhances cosmetic outcomes as well as oncological safety.
Advanced Reconstruction Methods
The emergence of reconstructive surgery in Kolkata has given patients who have undergone mastectomy the opportunity to have an immediate or delayed reconstruction with the help of implants or autologous tissue.
Reconstruction has been brought to improve psychological well-being, body image, and quality of life.
Influencing Factors of Surgical Decision-Making
The decision to use BCS or mastectomy is not only a medical choice, but a very personal one, which depends on several factors:
1. Cancer Stage and Tumor Characteristics
The main determinants include tumor size, location, and spread. BCS is more appropriate in early-stage cancers, whereas mastectomy is usually necessary in advanced cases.
2. Survival and Recurrence Outcomes
It has always been demonstrated that the survival rates are the same with BCS (including radiation) and mastectomy in the case of early-stage cancers. Nevertheless, BCS can be slightly more likely to recur locally, which can be treated.
3. Patient Preference
A major role is played by emotional and psychological factors. There are those patients who want to keep their breasts, and others opt to undergo a mastectomy to have peace of mind. Studies show fear of recurrence is a major driver for choosing mastectomy.
4. Access to Radiation Therapy
Since BCS requires post-operative radiation, access to treatment facilities can influence the decision. Patients without easy access may opt for a mastectomy.
5. Cosmetic and Quality-of-Life Concerns
BCS tends to provide superior cosmetic results and satisfaction. Nevertheless, the modern methods of reconstruction have also helped to enhance the results of mastectomy patients considerably.
Modern breast surgeons support a multidisciplinary patient-centered approach. Instead of prescribing a single solution, they consider:
Surgeons are increasingly preferring breast conservation surgery in most of the early-stage cases because of its good results and quality-of-life advantages. Nevertheless, mastectomy is necessary in more complicated or risky cases.
Conclusion
The debate between breast conservation surgery and mastectomy is no longer about which is superior, but about which is most appropriate for the individual patient. Oncoplastic techniques and reconstructive surgery in Kolkata have advanced, and patients now have a choice of safer, more personalized, and cosmetically satisfying options.
Credit: Canva
Heart failure has quietly emerged as one of India’s most serious and underestimated health challenges, driven by a rise in hypertension, diabetes, obesity, and delayed diagnosis of heart disease.
Due to a shortage of donor organs and a long waiting period before receiving the right treatment, end-stage heart failure patients in India faced a lot of difficulties a few years ago.
Today, advancements in heart transplant techniques are changing the situation from what was once an untreatable condition to a second chance at life.
Data from the National Organ and Tissue Transplant Organization (NOTTO) shows a significant year-on-year rise in heart transplants, with 253 transplants done in 2024, showcasing improved organ donation awareness, better coordination between hospitals, and stronger transplant networks.
What was once considered the only option is now emerging as a life-saving solution, offering patients not just a second chance but a return to a more meaningful and active life.
A heart transplant offers hope and gives a second life to patients whose hearts no longer support the body even after the best available medical aid.
Although it is never performed instantly, it becomes necessary whenever conditions of the heart result in end-stage heart failure, where the pumping function of the heart is compromised.
Also read: Harish Rana’s Family Donated His Heart Valves And Corneas After His Death From Passive Euthanasia
When medications and modern technologies cannot supply an adequate amount of blood and oxygen to the organs, patients experience extreme breathlessness, fluid buildup, fatigue, and repeated hospitalizations, making even simple activities like walking, eating, or lying flat exhausting.
As the flow of blood continues to deteriorate, failure is also expected in other vital organs such as the kidneys and liver. It is at this point that the transplantation of the donor heart is considered the only treatment option to ensure that the blood flow is normalized.
Heart transplant is not just a surgical replacement of a failing organ, but a complete life restoration for patients with end-stage heart failure.
Its benefits include:
© 2024 Bennett, Coleman & Company Limited